Thomas Fuchs is the founder of Cimeio Therapeutics. Cimeio Therapeutics has raised $50M in total funding. Latest round: Series A. Backed by Versant Ventures.
Thomas Fuchs was most recently CEO of Cimeio Therapeutics, a company he helped build, backed by a $50 million Series A financing round. He also secured a strategic collaboration agreement with Kyowa Kirin for Cimeio Therapeutics. Prior to this, he spent 15 years at Roche-Genentech, serving in senior leadership roles within the Global Haematology franchise.
Full founder directory · Investor directory · Company funding database · Fundraising library